| 查看: 228 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lw1966hhh铁杆木虫 (著名写手)
|
[交流]
研究一下路透社对小日本药物市场的分析《Jp Pharm Companies Outlook》
|
||
|
The Japanese Pharmaceutical Companies Outlook: An analysis of key players and growth strategies evaluates the strengths and weaknesses of the top 10 Japanese pharmaceutical firms' strategic and financial positions, marketed portfolios and pipeline compounds. This report will enable you to assess the market dynamics within the Japanese pharma market and understand how companies are positioning themselves at a time of significant change in their domestic market. The Japanese pharmaceutical market is the second largest in the world, behind only the US, with estimated sales of $52bn in 2002. While it makes it an attractive target for Western companies' expansion plans, low market growth (1% in 2002) has made the operating environment increasingly difficult for domestic players. Coupled with ongoing regulatory reforms and drug price cuts, which are largely intended to reduce the government's healthcare bill, Japanese companies are being forced to adapt their operating strategies. http://rapidshare.de/files/28238 ... es_Outlook_2004.pdf |
回复此楼» 猜你喜欢
药学 化学 生物学 生物与医药 河南师范大学抗病毒性传染病创新药物全国重点实验室
已经有0人回复
-
江西
已经有13人回复
-
药物学论文润色/翻译怎么收费?
已经有152人回复
-
江西科技师范大学086生物与医药
已经有15人回复
-
渐冻症病因及干预方案全新解析
已经有2人回复
-
求助用微谱数据库查询相关文献信息，非常感谢
已经有0人回复
-
NSCLC脑转移肿瘤模型
已经有0人回复
-
CHP-134这个细胞系哪里有？
已经有0人回复
